Javascript must be enabled to continue!
Electrocardiographic and echocardiographic abnormalities associated with mitral valve prolapse in patients with Marfan syndrome
View through CrossRef
Abstract
Introduction
Marfan syndrome (MFS) is responsible for cardiovascular disorders such as aortic aneurism and mitral valve prolapse (MVP).
A malignant MVP phenotype combining clinical, electrical and morphological features has been described in symptomatic patients who have experienced sudden cardiac death or complex ventricular arrhythmias.
We have taken advantage of the high prevalence of MVP in MFS patient to study the clinical, electrical and echocardiographic abnormalities associated with MVP.
Purpose
The aim of this study is to describe the clinical, electrical and morphological cardiac abnormalities associated with MVP in a cohort of MFS patients with FBN1 mutations with a high prevalence of MVP and who did not suffer from severe ventricular arrhythmias.
Methods
All consecutive patients coming to the National Reference Center for Marfan syndrome were evaluated prospectively i.e. clinical examination, 12-lead electrocardiogram, standard transthoracic echocardiography study and molecular genetic screening.
Results
352 consecutive patients were included from April 2015 to October 2016 [250 FBN1 mutation carriers (MFS) and 102 healthy relatives (HR)]. None of the patients had a history of sudden cardiac death or complex ventricular arrhythmia.
MFS vs HR: MFS patients were younger (33 vs 41yo p<0.001) and 2/3 were women in both groups. In the MFS group, abnormal T waves repolarization in lateral leads were more common [172 MFS (70.2%) vs. 87 HR (86.14%) p<0,0012], as was MVP [38.37% vs 1.96%; p<0,0001], and diastolic hypertrophy of the basal segment of the inferolateral wall (thickness >11mm) [22.31% vs. 9.18%; p<0.0001].
In MFS, MVP affected either one valve (21.22%), or both (17.14%), and was not associated with electric abnormalities. However, diastolic basal inferolateral wall hypertrophy was associated with mitral valve prolapse (p<0,0001), QTc interval prolongation (p<0.0229), abnormal T waves repolarization in the inferior leads (p=0.004), and higher aortic Z-Score (p=0.274).
Conclusion
In MFS patients, the prevalence of MVP is high and no significant association between MVP and electrical abnormalities was found. In contrast, basal inferolateral wall hypertrophy is associated with MVP and repolarization disorders in inferior leads and QTc interval prolongation, i.e, electrocardiographic abnormalities described in malignant MVP.
QTc and basal inferolateral hypertrophy
Funding Acknowledgement
Type of funding source: None
Oxford University Press (OUP)
Title: Electrocardiographic and echocardiographic abnormalities associated with mitral valve prolapse in patients with Marfan syndrome
Description:
Abstract
Introduction
Marfan syndrome (MFS) is responsible for cardiovascular disorders such as aortic aneurism and mitral valve prolapse (MVP).
A malignant MVP phenotype combining clinical, electrical and morphological features has been described in symptomatic patients who have experienced sudden cardiac death or complex ventricular arrhythmias.
We have taken advantage of the high prevalence of MVP in MFS patient to study the clinical, electrical and echocardiographic abnormalities associated with MVP.
Purpose
The aim of this study is to describe the clinical, electrical and morphological cardiac abnormalities associated with MVP in a cohort of MFS patients with FBN1 mutations with a high prevalence of MVP and who did not suffer from severe ventricular arrhythmias.
Methods
All consecutive patients coming to the National Reference Center for Marfan syndrome were evaluated prospectively i.
e.
clinical examination, 12-lead electrocardiogram, standard transthoracic echocardiography study and molecular genetic screening.
Results
352 consecutive patients were included from April 2015 to October 2016 [250 FBN1 mutation carriers (MFS) and 102 healthy relatives (HR)].
None of the patients had a history of sudden cardiac death or complex ventricular arrhythmia.
MFS vs HR: MFS patients were younger (33 vs 41yo p<0.
001) and 2/3 were women in both groups.
In the MFS group, abnormal T waves repolarization in lateral leads were more common [172 MFS (70.
2%) vs.
87 HR (86.
14%) p<0,0012], as was MVP [38.
37% vs 1.
96%; p<0,0001], and diastolic hypertrophy of the basal segment of the inferolateral wall (thickness >11mm) [22.
31% vs.
9.
18%; p<0.
0001].
In MFS, MVP affected either one valve (21.
22%), or both (17.
14%), and was not associated with electric abnormalities.
However, diastolic basal inferolateral wall hypertrophy was associated with mitral valve prolapse (p<0,0001), QTc interval prolongation (p<0.
0229), abnormal T waves repolarization in the inferior leads (p=0.
004), and higher aortic Z-Score (p=0.
274).
Conclusion
In MFS patients, the prevalence of MVP is high and no significant association between MVP and electrical abnormalities was found.
In contrast, basal inferolateral wall hypertrophy is associated with MVP and repolarization disorders in inferior leads and QTc interval prolongation, i.
e, electrocardiographic abnormalities described in malignant MVP.
QTc and basal inferolateral hypertrophy
Funding Acknowledgement
Type of funding source: None.
Related Results
Arrhythmic mitral valve prolapse: prevalence, characteristics, and high-risk features in children and adolescents
Arrhythmic mitral valve prolapse: prevalence, characteristics, and high-risk features in children and adolescents
Abstract
Introduction:
Arrhythmic mitral valve prolapse is a rare yet potentially fatal syndrome. Recently, high-risk mar...
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Background—
Little is known about the pathophysiology of myxomatous degeneration of the mitral valve, the pathological hallmark of mitral valve prolapse, associated wit...
DIAGNOSIS DAN TATALAKSANA SINDROM MARFAN
DIAGNOSIS DAN TATALAKSANA SINDROM MARFAN
ABSTRAK
Sindrom Marfan merupakan kelainan genetik jaringan ikat, bersifat autosomal dominan, dan disebabkan oleh mutasi pada gen fibrilin-1 gene (FNB1). Prevalensi sindrom ...
Prevalence of Mitral Valve Prolapse and Its Adverse Sequelae in Healthy Adult Yemenis
Prevalence of Mitral Valve Prolapse and Its Adverse Sequelae in Healthy Adult Yemenis
Background: Mitral valve prolapse is a common cardiac disease with frequent complications.
Objectives: To study the prevalence of mitral valve prolapse in healthy Yemenis ass...
Unmasking hidden risk: echocardiographic and electrocardiographic markers of arrhythmic risk in pediatric mitral valve prolapse
Unmasking hidden risk: echocardiographic and electrocardiographic markers of arrhythmic risk in pediatric mitral valve prolapse
Abstract
Background
Mitral valve prolapse (MVP) is a common valvular condition characterized by systolic displacement of ...
Bicoronary-pulmonary fistulae and severe mitral valve regurgitation – uncommon cause of myocardial ischemia – a case report
Bicoronary-pulmonary fistulae and severe mitral valve regurgitation – uncommon cause of myocardial ischemia – a case report
Abstract
Bicoronary - pulmonary artery fistulae are rare conditions. Their association with mitral valve prolapse is even rarer and randomly reported. This association is impo...
Transcatheter mitral valve-in-valve implantation: a 10-year single center experience
Transcatheter mitral valve-in-valve implantation: a 10-year single center experience
Abstract
Background
Transcatheter mitral valve-in-valve (TMVIV) appears a reasonable alternative to surgical redo mitral valve r...
Echocardiographic predictors of operative outcome for transapical off-pump mitral valve repair with neochord implantation
Echocardiographic predictors of operative outcome for transapical off-pump mitral valve repair with neochord implantation
Abstract
Introduction
Transapical off-pump mitral valve repair with artificial neochord implantation (TOP-MINI) is safe and effe...

